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Abstract
Background: Carbonaceous nanoparticles (CNP) represent a major constituent of urban particulate air pollution,
and inhalation of high CNP levels has been described to trigger a pro-inflammatory response of the lung. While
several studies identified specific particle characteristics driving respiratory toxicity of low-solubility and low-toxicity
particles such as CNP, the major lung cell type, which initiates and drives that response, remains still uncertain.
Since alveolar macrophages (AM) are known to effectively phagocytose inhaled particles and play a crucial role for
the initiation of pulmonary inflammation caused by invading microbes, we aimed to determine their role for sterile
stimuli such as CNP by profiling the primary alveolar cell compartments of the lung. We exposed C57BL/6 mice to
20 μg CNP by intratracheal instillation and comprehensively investigated the expression of the underlying
mediators during a time span of 3 to 72 h in three different lung cell populations: CD45- (negative) structural
cells, CD45+ (positive) leukocytes, and by BAL recovered cells.
Results: Bronchoalveolar lavage (BAL) analysis revealed an acute inflammatory response characterized by the most
prominent culmination of neutrophil granulocytes from 12 to 24 h after instillation, which declined to basal levels
by day 7. As early as 3 h after CNP exposure 50 % of the AM revealed particle laden. BAL concentrations and lung
gene expression profiles of TNFα, and the neutrophil chemoattractants CXCL1,-2 and-5 preceded the neutrophil
recruitment and showed highest levels after 12 h of CNP exposure, pointing to a significant activation of the
inflammation-evoking lung cells at this point of time. AM, isolated from lungs 3 to 12 h after CNP instillation,
however, did not show a pro-inflammatory signature. On the contrary, gene expression analysis of different lung
cell populations isolated 12 h after CNP instillation revealed CD45-, mainly representing alveolar epithelial type II
(ATII) cells as major producer of inflammatory CXCL cytokines. Particularly by CD45- cells expressed Cxcl5 proved
to be the most abundant chemokine, being 12 h after CNP exposure 24 (±11) fold induced.
Conclusion: Our data suggests that AM are noninvolved in the initiation of the inflammatory response. ATII cells,
which induced highest CXCL levels early on, might in contrast be the driver of acute neutrophilic inflammation
upon pulmonary CNP exposure.
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Background
Black carbon, the most strongly light absorbing-
component of particulate matter (PM), is an air pollu-
tant increasingly discussed to affect both human health
and climate change [1]. For Western Europe, traffic
seems to be the most important source and average
exposures of 6.5 ug/m3 have been described for people
in transport [2]. Black carbon is mainly present in the
form of soot particles within the so-called ultrafine,
nanoparticle fraction of anthropogenic air pollution, but
in addition to the inhalation of combustion-derived
nanoparticles, the workplace can also be an important
site of exposure in the case of manufacture of carbon
black. Due to its small size, inhaled carbonaceous nano-
particles (CNP) have been described to effectively pene-
trate deep into the lungs, deposit in the fragile alveolar
region and might thus be more potent to induce health
effects than lager particles [3–5]. Even that associations
of specific sub-components of PM with adverse effects
are difficult to detect for epidemiological studies,
combustion-derived particles had been identified as
an important component in driving adverse effects of
PM already years ago [6, 7]. In this context the WHO
report 2012 recognizes sufficient evidence of epide-
miological studies for an association of daily variations in
black carbon concentrations with short‑term changes in
health (here: all‑cause and cardiovascular mortality, and
cardiopulmonary hospital admissions), and suggest BC to
be a better indicator of harmful particulate substances
from combustion sources (especially traffic) than undiffer-
entiated PM mass. We and others have used carbon nano-
particles of various sources, such as Printex 90 or Sterling
V to examine the underlying toxicological mechanisms in
animal and human studies [8–12]. While these CNPs
exhibit difficulties in the aerosolization of agglomerated
black carbon powders in the ultrafine or nanosized mode
(<100 nm count median diameter), freshly, lab generated
CNPs have been used for inhalation studies in mice
[13, 14], rats [15], and man [16, 17]. Depending on
the focus of interest and also the doses applied, these
studies describe low grade pulmonary inflammation,
trombogenicity, cardiovascular impairments and alter-
ations in the peripheral blood leukocyte distribution
upon CNP exposure.
With regard to the initiation event that leads to the
observed exacerbations of cardiorespiratory effects
caused by inhaled particles, the most-recognized hypo-
thesis is the oxidative stress paradigm. According to this
hypothesis the underlying pathophysiological mechanism
of particle toxicity for so called low-solubility and low-
toxicity particles (LSLTP) is dependent on particle trig-
gered oxidative stress and subsequent inflammation
[18, 19]. The most prominent feature for this innate
immune response is the recruitment and activation of
granulocytes, specifically neutrophils, to the site of stimulus,
here the site of pulmonary particle deposition [20, 21]. For
LSLTP such as titanium dioxide, polystyrene or carbo-
naceous nanoparticles (CNP), the particle induced pulmon-
ary inflammatory effect, assessed as number of neutrophils
accumulated in the airspace of the lungs, is predominantly
driven by oxidative surface properties of the pulmonary
deposited particle [22]. As consequence and due to their
high specific surface area, nanoparticles have been shown
to be more inflammogenic than fine particles of identical
chemical composition [20, 23, 24].
However, which cell type upon particle deposition
finally initiates the inflammatory cascade remains ob-
scure. Broadly speaking the alveolar compartment, as
main site of nanoparticle deposition and retention,
consists of three different cell types which line the alveo-
lar surface and are thus directly in contact with the
deposited particles: type I (ATI) and type II (ATII) alveo-
lar epithelial cells and in the epithelial lining fluid
nestled alveolar macrophages (AM). Even that a ‘three
cell model’ is oversimplified, and various other immune
relevant cell types such as dendritic cells, mast cells, inter-
stitial macrophages and fibroblasts will have to be consi-
dered [25], we like to start from this simplistic view and
focus here at the alveolar surface, which is likely bearing
the highest particle burden upon CNP inhalation. AT1
cells cover 98 % of the alveolar surface [26, 27], ATII cells
secrete surfactant, maintain the fluid balance and have
been described as defender of the alveolus [28]. The tissue
resident AM are known for their effective uptake of
deposited particles and also nanoparticles [29], and me-
diate acute lung inflammation and resolution in many
disease conditions [30].
The recruitment of neutrophils to the site of injury is
generally initiated by the binding of the neutrophil che-
moattractants CXCL1, -2 and -5 to the neutrophil che-
mokine receptor CXCR2 [20]. CXCL1 can be expressed
by macrophages, neutrophils and epithelial cells during
the inflammatory response [31]. CXCL2, also referred to
as MIP2α (macrophage inflammatory protein 2-alpha),
in contrast is mainly secreted by monocytes and macro-
phages [32]. CXCL5, also known as ENA-78 (epithelial-
derived neutrophil-activating peptide 78), is a small cyto-
kine and mainly expressed by epithelial cells [33, 34].
Till today no specific signaling receptor or cell type
recognizing sterile particles such as CNP or other LSLTP
has been described and related to the evoked inflam-
matory response in the lung. Even that promising studies
have recently uncovered the activation of e.g. epidermal
growth factor (EGF) receptor [35] or pattern recognition
receptors by different nanoparticles [36], it is still
unclear how relevant this interaction may act as initial
trigger for the inflammatory response, caused by inhaled
LSLTP particles. Since our mechanistic understanding of
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the early phase of the cellular course of events from
particle deposition to neutrophil accumulation in the
alveolar airspace of CNP exposed lungs remains elusive,
we might be tempted to compensate this gap by emplo-
ying a well-established mode of action, such as the one
known for neutrophil recruitment triggered by bacterial
infection. Here pathogen-associated molecular pattern
are recognized by specific pattern recognition receptors
and tissue macrophages are considered crucial sensors
for pathogen-invasion and cell damage. A similar macro-
phage based understanding exists for the pulmonary
toxicity of quartz particles and fibers. Particle phagocyt-
osis of needle like shapes or particular crystals can
combined with the material specific high surface reacti-
vity cause lysosomal destabilization, which sensed by the
NALP3 inflammasome, leads to the release of the pro-
inflammatory master cytokine IL-1β from particle laden
macrophages [37, 38]. In addition to that, IL-α had been
described as a alarmin cytokine, upstream of IL-1β,
which is released from AM already in the first hours
after silica particle deposition [39]. None of these activa-
tion mechanisms have so far been observed for pyrogen-
free, spherical carbon nanoparticles, and a specific role
of AM in sensing these particles as a danger pattern
remains uncertain.
Several, but mainly in vitro based studies, suggest a
central function of the respiratory epithelium for the
inflammatory response caused by carbonaceous nano-
particles. In this context it has been described that fine
PM induces amphiregulin secretion by bronchial epithe-
lial cells [40]. Our previous CNP inhalation study also
detected induced pulmonary expression of this epider-
mal growth factor (EGF)-like molecule [13]. In vitro,
high doses of CNP have been shown to trigger, apoptosis
and proliferation of ATII cells via pathways using EGF-
receptor signaling [41]. The amphiregulin EGF-receptor
interaction may also cause MAP-kinase activation and
thus function as a pro-inflammatory feedback loop in the
lung epithelium [42]. But again, the in vivo relevance of all
these epithelial or macrophage pathways for the initiation
of CNP triggered inflammation is not confirmed.
Therefore, in this study, we aimed to identify the
pulmonary cell type, which initiates the inflammation
and produces the neutrophil chemoattractants upon
CNP exposure. Since the majority of inhaled nanopar-
ticles are rapidly incorporated by AM, thereby posing
the highest cellular dose to these cells, and since acti-
vated macrophages are in general well known for their
extreme cytokine production capability, we hypothesize
that alveolar macrophages play a key role for the initiation
of CNP induced lung inflammation. In order to address
this question, we performed a time course analysis to
identify the onset of the inflammatory response, isolated
AM by Bronchoalveolar lavage (BAL), CD45+ lung tissue
leukocytes and CD45- lung epithelial cells from the CNP
instilled mice and examined the expression of inflamma-
tory genes and neutrophil chemoattractants. Much to our
surprise however, a comparison of the gene expression
profiles of the three isolated cell populations uncovered an
essential role of the alveolar epithelium, most likely type II
(ATII) cells, for the production of the neutrophil chemo-
attractant at the onset of CNP induced inflammation, but
not for the particle laden AM. Also no activation of alveo-
lar macrophages preceding the cellular inflammation
could be detected during the first 3 to 12 h after exposure.
Results
We used a single dose of 20 μg/mouse of carbon nano-
particles (CNP) generated by spark discharge from graph-
ite electrodes to induce an aseptic, acute neutrophilic
inflammatory response in the lungs of healthy C57BL/6
mice by intratracheal instillation (IT). Particle dispersions
where characterized by a mean agglomerate size of
190 nm (DSL) consisting of primary carbon particles of
7–12 nm (Additional file 1: Figure S1).
In comparison to sham treated controls, the IT deliv-
ery of 20ug CNP induced no detectable histological
alterations in the epithelial architecture of the lungs
within 24 h after instillation. However, particle laden
alveolar macrophages (AM) can be detected in the
alveoli and even more prominent on cytospin prepara-
tions of by BAL recovered cells from CNP treated lungs
(Fig. 1). The appearance of particle laden AM was
accompanied by an accumulation of polymorphonuclear
neutrophils (PMN) 24 h after CNP IT. No particle
agglomerates could be detected in structural cells, such
as ATII cells.
Time course response of BAL cells
We first performed a time course analysis to deter-
mine the starting point of the onset of the inflamma-
tory response on the cellular as well as the molecular
level. Accordingly, mice were sacrificed 3, 6, 12, 18,
24 h and 3 or 7 days past a single IT dose of 20 μg
CNP, and BAL was analyzed for the influx of inflam-
matory cells and cytokines, and by qPCR for pro-
inflammatory gene expression in lung homogenates.
Counting the frequency of BAL cells with visible in-
clusions of back particle agglomerates (CNP) revealed
a rapid increase of particle laden macrophages from
50 % already 3 h, to 90 % 12 h after CNP exposure.
No CNP uptake was detected for neutrophils and free
agglomerates were virtually absent for time points
later than 12 h after CNP exposure (Fig. 2).
As depicted in Fig. 3, BAL cell differentiation re-
vealed an acute, neutrophilic pulmonary inflammation,
where neutrophilic granulocytes (PMNs) represent the
most significant cell accumulation with 0.25 × 106
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PMNs 24 h after CNP instillation. Nevertheless, also
3 h after CNP, the first time point analyzed, a smaller
number of 0.04 × 106 PMNs could be detected, whereas
PMNs were basically undetectable in untreated con-
trols (below 1 %; <2 × 103 cells). The increase in BAL
PMN numbers was most dynamic from 12 to 18 h
after treatment, with a significant increase from 0.10
to 0.23 x106 PMNs within 6 h. Lymphocyte numbers
were nearly undetectable (<1 % of total BAL cells)
and macrophages showed a noticeable decline at the
12 h time point and an increase after 24 h only. The
acute inflammatory response resolved over time,
reaching BAL neutrophil levels similar to baseline by
day 7.
Time course response of neutrophil chemoattractants in
BAL and lung homogenate
Since the chemotactic recruitment of PMNs from the
blood to the airspace is driven by chemokines released
from different resident alveolar cells [25, 43], we next
studied BAL levels of CXCL1,-2, and-5 as well as those
of the well-known pro-inflammatory master cytokine
TNFα during the inflammatory time course. As dis-
played in Fig. 4a, BAL concentrations of CXCL1, CXCL5
and TNFα showed a similar release pattern, with highest
levels 12 h after CNP exposure. CXCL2 exhibited a more
biphasic response, with highest levels at 6 and 12 h after
treatment. In contrast to BAL PMN numbers, all investi-
gated cytokine levels had dropped to baseline already by
Fig. 1 CNP agglomerates are engulfed by alveolar macrophages. The histological examination of hematoxylin and eosin stained lung sections
(upper panel) reveals no detectable changes in the lung architecture, 24 h after sham and CNP instillation. A spotty accumulation of particle
laden alveolar macrophages can be observed in the alveolar region of CNP treated lungs. Cytospin analysis of May Grunwald stained BAL cell
(lower panel) underlines this finding and also indicates the inflammatory response by accumulation of neutrophilic granulocytes (black arrow).
A magnification of particle laden macrophages, shown in the framed sections is illustrated at the upper (histology) and lower (BAL cells) right
corner of the respective image
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day 3, and TNFα concentrations were falling even below
that of controls. With regard to the escalation of the
BAL cytokine concentrations at 12 h after CNP, CXCL1
and CXCL5 levels actually multiplied by a factor of 30
and eight respectively, whereas TNFα and CXCL2 levels
were as compared to controls induced only less than
threefold. CXCL1 and-5 reached highest absolute BAL
concentrations, with 850 and 640 pg/ml respectively,
suggesting these two cytokines to be of major impor-
tance for the particle exposure triggered PMN recruit-
ment to the airspace. Moreover, a significant increase in
gene expression in lung homogenates for Cxcl1,-2,-5,
and to a lower extent also for Tnf was detected by quan-
titative RT-PCR from 6 h to 12 h after CNP instillation
(Fig. 4b). Cxcl and Tnf expression levels returned to
baseline by day 3. We therefore consider the period from
6 h to 12 h after CNP instillation as the most critical
phase for the cellular and transcriptional activation of
the respective lung cells initiating the inflammatory
response.
CNP instillation has no impact on the inflammatory status
of alveolar (BAL) macrophages
Since AM rapidly and effectively incorporate high bur-
den of alveolar deposited CNPs (Fig. 2) and can there-
fore be considered to bear the highest cellular CNP
dose, we next examined the activation status of these
cells in dependence of the particle exposure. AM were
isolated from mice by BAL either 3 and 12 h after sham
treatment, or 3, 6 and 12 h after CNP IT and processed
for qPCR. Expression analysis of the genes related to
classical pro-inflammatory macrophage activation, Nos2
Fig. 2 Time course of CNP agglomerate uptake. The amount of by BAL recovered cells showing inclusions of CNP agglomerates was quantified
by the examination of cytospins from mice 3 to 24 h after particle instillation. Particle uptake was exclusively observed for macrophages but
and no agglomerates we observed in polymorphonuclear, neutrophilic granulocytes (a). Free, not cell-associated particle agglomerates are
predominantly detected at the early time points, till 12 h after exposure. Figure 2b shows the time course of the particle uptake given
as the percentage of particle laden macrophages
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(nitric oxide synthase 2, inducible), Tnf and Il1b (Fig. 5a,
and Additional file 1: Figure S5A) showed no exposure
related changes. Also the Cxcl genes which showed
significant upregulation in lung homogenates at 12 h
after CNP treatment (Fig. 4b), revealed unresponsive in
BAL AMs, 3, 6 and 12 h after CNP IT (Fig. 5a, and
Additional file 1: Figure S5A). Noteworthy, under
control conditions Cxcl1,-2 and-5 showed higher expres-
sion levels in BAL macrophages as compared to lung
tissue extracts, but 12 h after CNP, total lung expres-
sions exceeded those of AMs by magnitudes. In addition
expression of the pro-inflammatory NF-kB pathway
responsive genes Nfkbia, Nfkbib, and Nfkbiz (nuclear
factor of kappa light polypeptide gene enhancer in B
cells inhibitor alpha,-beta,-zeta) [44] did not show any
change upon particle challenge in BAL AMs (Fig. 5c and
Additional file 1: Figure S5). In contrast to the CNP
exposure, instillation of endotoxin (0.1 μg LPS) caused a
Fig. 4 Time-course analysis of cytokine release and gene expression demonstrates most significant expression inductions from 6 to 12 h after
CNP exposure: Concentrations of CXCL1,-2,-5 and TNFa cytokines were quantified by ELISA in BAL fluid from mice 3 h to 7 days after CNP
exposure (a). Highest levels were detected at 12 h after CNP. Similarly, gene expression of Cxcl1, Cxcl2, Cxcl5 and Tnf determined by qPCR
in whole lung tissue revealed the most notable expression inductions from 6 h to 12 h after treatment (b). Relative expressions are provided,
normalized to Hprt and Actb. All values are given as mean ± SEM, n = 5–10, asterisks represent significance as compared to control group
with *p < 0.05, **p < 0.01 and ***p < 0.001
Fig. 3 BAL cell numbers time course analysis reveals most dynamic PMN accumulation between 12 and 18 h after CNP exposure: The numbers
of total BAL cells, alveolar macrophages (AM) and neutrophils (PMN) were determined by BAL cell differentiation from cytospin preparations of
mice treated with 20 μg CNP for 3, 6, 12, 18, 24 h, and 3 or 7 days and compared to untreated controls. Most notable changes were observed
for PMNs which are almost absent in controls (<1 %) but reach greatest numbers 18 and 24 h after exposure. Values are given as mean ± SEM,
n = 5–10, asterisks represent significance as compared to control group with * p < 0.05, **p < 0.01 and ***p < 0.001. BAL lymphocyte numbers
were below 1 % of total BAL cells in all groups (data not shown)
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vigorous activation of the isolated BAL macrophages
12 h after, resulting in the well-known classical activa-
tion profile (Additional file 1: Figure S5). Altogether
these data support the notion that the population of
BAL isolated macrophages is not activated by particle
instillation and thus does not seem to contribute to the
inflammatory CNP response of the lung.
Alveolar epithelial cells are a major producer of
neutrophil attracting chemokines early after CNP
treatment
To better understand which lung cells finally accomplish
the pro-inflammatory gene expression profile observed
12 h after CNP exposure (Fig. 3b), we divided the lung
homogenates of sham and CNP exposed mice in three
different cell populations: CD45- (negative) structural
lung cells, CD45+ (positive) lung leukocytes, and by
BAL recovered cells (here not differentiated in adhe-
rent macrophages and non-adherent leukocytes). Cell
purification was confirmed by expression profiling for
the cell specific markers Cd68 (macrosialin) for
macrophages. CD45- (negative) structural lung cells
were almost exclusively (>95 %) composed of alveolar
epithelial type II (ATII) cells, which was confirmed by
Aqp1 (aquaporin 1) transcript level as well as immu-
nostaining for- proSFTPC (pro surfactant protein C),
cytokeratin (both positive) and α-Sma (α-smooth muscle
actin), CD31, CD45, T1α (negative) (Additional file 1:
Figure S2 and S3).
Comparative gene expression profiling highlighted that
only ATII (CD45-) cells, but not CD45+ lung leukocytes
or BAL cells, depict prominent induction of Cxcl1 and-5
mRNA levels. In fact, from the populations covered by
our study, the main expression of Cxcl1 and-5 can be
allocated to ATII cells, whereas Cxcl2 is predominantly
expressed but not CNP-induced by lung and BAL leuko-
cytes (Fig. 6a). Neither of the macrophage activation
markers or pro-inflammatory master cytokines Nos2,
Fig. 5 No effect of CNP IT on pro-inflammatory activation status of alveolar macrophages: Alveolar macrophages were isolated by BAL from mice
12 h after water (sham) or 6 and 12 h after CNP IT. Gene expression of the macrophage activation markers Nos2, Tnf and Il1b (a), the chemokines
Cxcl1, Cxcl2 and Cxcl5 (b) and the NF- kB signaling pathway genes Nfkbia, Nfkbib and Nfkbiz (c) are presented relative to Actb + Hprt. Values are
given as mean ± SEM, n = 4–5. (n.d.: not detected)
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Tnf and Il1b showed a conclusive expression profile
supporting the inflammatory activation of CD45+ lung
or BAL leukocytes (Fig. 6b and Additional file 1: Figure
S4). To identify inflammatory activated cells also in situ,
we applied a NF-kB1-GFP reporter mouse strain to
visualize cell activation by anti-GFP immunohistoche-
mistry in lung sections and BAL cell cytospin prepa-
rations (Additional file 1: Figure S6). While no cellular
GFP accumulation could be detected in samples from
controls or CNP (12 h) exposed mice, strong anti-GFP
staining was observed for epithelial cells and macro-
phages of the LPS positive control (12 h).
In summary our results suggested a pivotal role of
structural lung cells, in particular ATII cells, for the
production and release of neutrophil attracting CXCL
chemokines within the acute inflammatory response
after CNP instillation. Alveolar macrophages in contrast
seem not involved and do not get activated within the
first 12 h after CNP exposure, despite of their prominent
particle loading.
Discussion
The inflammatory response is governed by a series of
well-orchestrated intracellular and extracellular signaling
events that control the expression and release of im-
mune mediators, such as pro-inflammatory cytokines
and chemokines [45]. One of the most important param-
eter and characteristics of acute inflammation is the
migration of leukocytes to the site of injury. Particularly
the accumulation of neutrophil granulocytes represents
an essential defense strategy of the innate immune
system and is recognized as the hallmark of acute
inflammation [46]. The aim of the present study was to
gain insight into the initiation of inflammation trigged
by the inhalation of low-solubility and low-toxicity parti-
cles such as carbonaceous nanoparticles; more parti-
cularly we ask the question which cell type in the
periphery of the lung may be the first activated and thus
initiate the inflammatory response upon pulmonary
particle deposition. In particular we raised the hypo-
thesis that alveolar macrophages, the major phagocytes
of the alveolus, get rapidly activated upon particle
uptake and as consequence stimulated to express infla-
mmatory mediators to kick-start the local inflammatory
immune response.
We have chosen well-defined, lab-created carbon
nanoparticles (CNP), which according to our previous
work trigger significant lung inflammation within 24 h
after instillation, at a moderate dose of 20 μg per mouse
[12, 47]. We consider these particles as well suited
representative for the so called ‘low-solubility and low-
toxicity particles’ and have characterized them as virtu-
ally pure carbon particles without a considerable content
of bio-active organic carbon compounds [48, 49], or
endotoxin. The latter was confirmed by the absence of
any inflammatory response in experiments with different
murine macrophage cell lines, known for their endo-
toxin sensitivity (data not shown), and most importantly
Fig. 6 Alveolar epithelial cells are the main producers of neutrophil attracting chemokines: CD45- (alveolar epithelial cells), CD45+ leukocytes and
total BAL cells were isolated from mice 12 h after the treatment with water (sham) or CNP. Gene expression analysis is shown for the chemokines
Cxcl1, Cxcl2 and Cxcl5 (a), and the macrophage activation marker Nos2, Tnf and IL1b (b). Expression levels are given relative to Actb + Hprt.
Results show means and SEM out of three replicas and the expression pattern is representative for four independent experiments
Chen et al. Particle and Fibre Toxicology  (2016) 13:33 Page 8 of 15
also by the lack of any pro-inflammatory CNP triggered
macrophage stimulation in the current study. We have
further chosen intratracheal instillation (IT) as delivery,
superior to the more natural route of inhalation, because
of the ease of dosimetry and the definite time point of
pulmonary dose deposition as a result of the bolus IT
delivery. In a previous CNP inhalation study we had in
this context detected a bi-phasic gene expression
response, characterized by an initial stress response
phase during the first 4 h of CNP inhalation, followed by
the inflammatory phase in the following 20 h [13]. This
response pattern may be seen as a consequence of a
gradually increasing dose accumulation combined with
proceeding cellular stress and activation processes.
In the present study we first set out to define the time
point of the onset of the cellular inflammatory response.
BAL cell differentiation clearly indicated the main influx
of PMNs into the alveolar airspace, to take place
between 12 and 18 h after CNP IT, with the point of
culmination around day 1 (Fig. 3). The neutrophilic
inflammation showed a transient nature, and was com-
pletely resolved till day 7, which matches well with the
absence of any histological changes or signs of sizeable
lung tissue injury, which otherwise would decelerate the
resolution process. A distinct expression and release of
neutrophil attracting CXCL chemokines, accompanied
and preceded the inflammatory recruitment of PMNs, in
a way that Cxcl1,-2 and-5 gene expression increased
most rapidly from 6 h to 12 h after the particle challenge
(Fig. 4b) and yielded highest cytokine concentrations
around 12 to 18 h after treatment. The 12 h time point
showed also the most prominent activation of the NF-
kB1 pathway in lung homogenates, indicated by electro-
phoretic mobility shift assay analysis of the specific
recognition sequence for NF-kB, and the maximal
expression of the NF-kB responsive genes Nfkbib, and
Nfkbiz (data not shown).
This raises the question of which cells do actually get
activated to drive the inflammatory response and gene-
rate the cytokine boost observed 12 h after CNP expo-
sure. The most obvious candidate for the cell type which
triggers the inflammation response to pulmonary
particle deposition may be seen in the alveolar macro-
phage (AM). We have previously shown in rats, that
already after a 6 h gold nanoparticle (14 nm) inhalation,
particles were found in 94 % of the BAL AMs directly
after the exposure period [29]. Accordingly also in the
present study, carbon black laden AM were detected in
the lungs already 3 h after CNP instillation, pointing to
the highest cellular dose experienced by these tissue
resident phagocytes. In view of the well-described
potency, and necessity of AMs to respond to pathogens
and to kick-off the local defenses against infection
[50–52], we hypothesized that the massive contact
with particles would induce an inflammatory acti-
vation of these cells. In this context, Brown et al. [53]
showed the activation of rat AMs in vitro, by
increased intracellular calcium, AP-1 transcription
factor activation and TNFα production, all triggered
by high doses of a very similar type of 14 nm CNP
(Printex 90). So far however, no clear in vivo evidence
was presented for the direct activation of AMs by
pulmonary exposure to pure carbon particles.
Our expression analysis of by BAL recovered AMs
from lungs 3, 6 and 12 h after CNP treatment, clearly
contradict with the concept of AMs as the cellular in-
flammation trigger. In fact, AMs from CNP instilled
mice showed in comparison to sham exposed or
untreated controls, no sign of inflammatory activation.
The expression of the major transcriptional markers for
classical (M1) macrophage activation, Nos2 and Tnf
showed no exposure related change, neither 3, nor 6, or
12 h after CNP treatment, nor was any other of the pro-
inflammatory genes investigated such as Il1b, Cxcl1,-2,-5
or Nfkbia,-b, and –z, induced by the CNP treatment.
Notwithstanding, all these M1 marker genes exhibited a
significant induction within 12 h after a moderate endo-
toxin stimulation (Fig. 5). Other activation markers such
Il6 or Ccl2 and also the most prominent factor Arg1 for
alternative (M2) activation remained unchanged in AMs
12 h after CNP treatment.
On the basis of the total lack of pro-inflammatory
responses in BAL AMs we had to reconsider our
hypothesis of AMs being the alveolar cell population
initiating the inflammatory stimulation. We therefore
expanded our analysis to different primary cell isolates
of the lung periphery from CNP and sham treated mice,
to identify the cell type showing the most obvious
inflammatory expression profile. From lavaged lungs we
separated cells into CD45- lung epithelial cells and
CD45+ lung leucocytes, and by lavage recovered BAL
leucocytes. Immunohistochemical characterization re-
vealed CD45- cells to be largely alveolar epithelial type II
(ATII) cells (>95 %). This characterization completely
agrees to previous characterizations of this way prepared
lung cells [54–56] In fact this population showed the
most robust induction of Cxcl1 and-5 gene expression
12 h after CNP exposure in relation to sham exposed
lungs (Fig. 6a). The data thus suggests that ATII cells are
an important source for the CXCL1 and-5 cytokine
release observed 12 and 18 h after particle treatment
(Fig. 4a). Noteworthy, CXCL1 and-5 were the most
abundant chemokines identified, and were found to be
released at concentrations of 600–900 pg/ml BAL fluid.
In the contrary neither CD45+ lung leukocytes, nor BAL
cells showed any sign for an inflammatory stimulation
and marker genes like Cxcl2, Tnf, Nos2 and IL1b
remained basically unchanged at the time point of
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investigation (Fig. 6b). This lack of inflammatory activa-
tion of total BAL cells after 12 h matched well with that,
described before for BAL macrophages 3, 6 and 12 h
after treatment, and supports the conclusion that AMs
do not contribute to the initiation of the inflammatory
response under sterile conditions. This of course was in
sharp contrast to the by bacterial endotoxin provoked
inflammation, were macrophages where characterized by
abundant NFkB1 activation (Additional file 1: Figure S6)
and pro-inflammatory gene expression (Additional file 1:
Figure S5). It should be noted at this point, that the BAL
cell population analyzed for Fig. 6 contains for the 12 h
post CNP IT group already a great number of granulo-
cytes (see Fig. 3) and the expression profiles do therefore
not completely match with those shown in Fig. 5 for
purified alveolar macrophages (see Additional file 1:
Figure S4 for details). Hence the exposure related
increases in Tnf and Il1b in BAL cells are likely attribu-
table to leukocytes not present after purification.
Our observations, seem contradicting with the well
described ability of AMs to produce a great number of
pro-inflammatory cytokines upon the phagocytosis of
environmental particles, a process caused by classical
activation of these cells [19]. Also carbon black particles
had been reported to generate ROS, cause a transient
increases of intracellular calcium, and subsequently lead
to the expression and release of TNFα in rat AM via
activation of NF-KB and AP1 [53]. Therefore, our initial
expectation was that lung macrophages contribute to
the production of pro-inflammatory cytokines and che-
mokines to recruit circulating neutrophils to the alveolar
space. In this context, we also exposed primary AMs
and cells of the murine alveolar macrophage cell line
MH-S to CNP in vitro, at doses up to 100 μg/ml. In
contrast to Browns finding, we could not detect any
induction of TNFα transcription or protein release. Yet
exposure of MH-S cells to ambient PM2.5 effectively
caused TNF expression and release, as did LPS [57]. The
different outcomes for the similar carbon black particles
might eventually be related to the different doses used.
We however think that in vitro doses beyond 100 μg/ml
medium are too excessive and likely to cause artefacts.
In summary, although that particle uptake in CNP
exposed lungs can clearly be observed by the rapid accu-
mulation of particle laden AMs (Fig. 2) these resident
lung cells do not react to the CNP exposure with a
classical pro-inflammatory activation during this initial
phase, preceding the cellular inflammation (3–12 h). In
contrast to this finding for insoluble, pure carbon parti-
cles, ambient PM samples are known for their potency
to trigger the release of pro-inflammatory cytokines such
as TNFα and IL-6 from exposed AMs [57], and this
cytokine response is assumed to be crucial for the sub-
sequent stimulation of the epithelium [58] or even
cardiovascular effects beyond the lungs [59]. In our
study CNP IT also induced highest levels of BAL IL-6
concentrations with up to 800 pg/ml 12 h after treat-
ment, in comparison to levels below 10 pg/ml in
controls, but again no exposure related change of Il6
gene expression could be detected in macrophages,
neither in CD45+ nor in BAL cells at the same time
point of investigation. Due to contaminations in ambient
PM samples, such as airborne bacterial endotoxin or
reactive metallic compounds, the described PM triggered
induction of the pro-inflammatory cytokine release for
AMs may however differ from that driven by pure
carbon particles. On a related note, the initiation of CNP
triggered inflammation seems also independent from the
alarmin release mechanism, recently uncovered for
crystalline silica particles [39]. In their study the authors
describe the release of the tissue damage alarmin IL-1α
from AM directly after pulmonary silica particle depo-
sition. Opposed to this, no change in IL-1α BAL-levels
could be detected in the CNP instilled lungs up to 24 h
after exposure (data not shown), again arguing for a dif-
ferent kind of trigger for pure carbon particles.
Seong and Matzinger discuss in their highly stimula-
ting review paper [60], how hydrophobic portions of
exogenous particles or molecules can serve as ligands
for different pathogen or damage associated molecular
pattern such as Toll-like receptors and thereby induce
an inflammatory response. From that view one might
expect that especially pure carbon particles, characte-
rized by high hydrophobicity such as the here investi-
gated CNP, should trigger such an ancient innate
immune responses via the activation of respective dam-
age associated molecular pattern (DAMP) receptors.
First in vitro evidence for this interaction could be pro-
vided by exposure of splenocytes, to gold nanoparticles
of different hydrophobicity [36]. Counter-intuitively and
in contrast to this appealing hypothesis however our
results deny an early exposition of DAMPs on the alveolar
surface, as these motives would certainly cause immediate
macrophage activation which we detected for LPS
(Additional file 1: Figure S5 and S6), but not CNP IT. It is
possible that the lung lining fluid and the thereby gene-
rated nanoparticle corona plays a protective role.
On the one hand we had to exclude AMs and probably
even lung leukocytes (CD45+ cells) as the driver and
initiator of CNP triggered neutrophil recruitment, on the
other hand our data support that alveolar epithelial cells,
and in particular the ATII cells play the crucial role in the
CNP induced inflammatory process. Besides secretion of
surfactant, ATII cells have also been shown to sense
invading pathogens to produce antimicrobial products
and amplify the inflammatory response by secretion of
cytokine and chemokines [61, 62]. Particularly for nano-
particles, the alveolar epithelial layer has been described
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to accomplish uptake and translocation of deposited ma-
terials [63, 64]. For agglomerated carbonaceous particles
this process might however be not effective enough [65]
to a detection of epithelial internalized CNP agglomerates
by light microscopy (Fig. 1). The fact that particularly
CXCL5, also called epithelial-derived neutrophil-activating
peptide 78 (ENA-78), is a specifically from inflammatory
epithelial cells released chemokine, and showed highest
expression levels 12 h after CNP instillation (Fig. 4),
clearly indicates an early inflammatory activation of the
epithelium by particle cell interactions. Unfortunately an
immunohistological in situ detection of NF-kB driven cell
activation failed in our hands for CNP exposed lungs, and
only approved significant AM and alveolar epithelial NF-
kB activation for LPS treated mice. Nevertheless, there is
good evidence for both cell types ATI and -II to express
and release CXCL5 under septic stimuli [33, 66, 67], but
which cell type is the major source for sterile or nanopar-
ticle triggered inflammation has after all not yet been
elucidated.
In our study, the inflammatory activation of the epithe-
lium showed a transient nature and resolved rapidly, in a
way that Cxcl5 gene expression declined by a factor of 20
from 12 h to 24 h after CNP treatment (Fig. 4b). The
time-course of maximal epithelial inflammatory activation
from 6 to 12 h after CNP suggests that the alveolar epithe-
lium gets stimulated by the deposited particles only for a
short period of time and then recovers to basal conditions.
One reason explaining this dynamic inflammatory kinetic
could be related to the rapid phagocytic particle clearance
by resident AM, as no increase in the percentage of
particle laden cells is observed 12 h after IT. In fact our
data suggests that the pulmonary deposited CNPs can
only develop their pro-inflammatory potency on the
epithelium until engulfed by macrophages. From that
point on the epithelial irritation can recover since CNP
laden AMs do obviously not promote inflammation but
rather remain inactive until eventually cleared by muco-
ciliary removal. In vitro exposure of ATII cells to high
doses carbon black nanoparticles has previously been
shown to stimulate the release of macrophage chemoat-
tractants [68], suggesting that structural cells might trigger
the chemotaxis of AMs to the site of particle deposition.
In this light the outdated term “dust cells” for alveolar
macrophages highlights their specification in a way that
for ‘low‐solubility low‐toxicity particles’ the essential func-
tion of AMs is limited to the removal of particles from the
lining fluid to prevent epithelial irritation and inflamma-
tion, but not to trigger inflammation itself.
Conclusions
We show that pulmonary carbon nanoparticle instilla-
tion triggers acute pulmonary inflammation, with no
inflammatory stimulation of alveolar macrophages, but
alveolar epithelial cells during the first 12 h after expo-
sure,-the period of the maximal induction of pro-
inflammatory gene expression. As alveolar deposited parti-
cles are rapidly removed by phagocytic clearance from the
respiratory surface, the epithelial inflammatory response
seems short-lived as long as particle laden macrophages
remain unstimulated. Yet inhaled materials which are
difficult to clear by phagocytosis or pose toxicity and per-
sistent stimulation to alveolar macrophages, may cause
persistent inflammation and should therefore be desig-
nated more hazardous than ‘low-toxicity low-solubility
particles’ such as carbon nanoparticles.
Methods
Carbon nanoparticles
Carbon nanoparticles (CNP) were generated by spark
discharge from graphite electrodes as previously described
[47, 69]. The sterile and pyrogene-free produced particles
consist of over 96 % pure carbon and primary particles are
characterized by an isometric/spherical shape with a
diameter of 7–12 nm and a specific surface area of
800 m2/g [12, 49]. CNPs were dispersed in pyrogene-free
distilled water (Aqua ad iniectabilia, Braun, Melsungen,
Germany) at a concentration of CNP 0.4 μg/μl and soni-
cated twice for 30 s with a probe sonicator (SonoPlus
HD70, Bachofer, Berlin, Germany) at 30 % amplitude
(70 W) on ice. CNP dispersions showed a mean agglome-
rate size of 0.19 μm, measured by dynamic light scattering
(Malvern Zetasizer Nano ZS). The absence of endotoxins
and pyrogens from the particle preparation was approved
by LIMULUS assay and even more relevant by in vitro
studies using different murine macrophage cell lines (data
not shown).
Animals
Female C57BL/6 J mice at the age of 8–10 weeks were
received from Charles River Laboratories, Sulzfeld,
Germany. Prior to the CNP exposure, the animals were
kept for a minimum of two weeks in isolated ventilated
cages (IVC-Racks; BioZone, Margate, UK) supplied with
filtered air, in a 12-hr light/12-hr dark cycle at animal
facility of Institute of Lung Biology and Diseases at the
Helmholtz Zentrum München, for acclimatization. Spe-
cific pathogen-free hygienic status was approved by a
health certificate according to Federation of Laboratory
Animal Science Associations guidelines [70]. Food and
water were available ad libitum. Animals were treated
humanely and with regard for alleviation of suffering;
experimental protocols were reviewed and approved by
the Bavarian Animal Research Authority and by the
Institutional Animal Care and Use Committee of the
Helmholtz Center Munich.
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Nanoparticle exposure
Mice were exposed with either pyrogene-free distilled
water (Aqua ad iniectabilia, Braun, Melsungen, Germany)
for sham groups or 20 μg CNP in 50 μl water for expe-
rimental groups by intratracheal instillation as described
previously [8–12]. Briefly, mice were anesthetized via
intraperitoneal injection of a mixture of medetomidin
(0.5 mg/kg bodyweight), midazolam (5 mg/kg body-
weight), and fentanyl (0.05 mg/kg bodyweight) and
intubated by a nonsurgical technique, using a cannula
inserted 10 mm into the trachea, for instillation. For the
time course experiments of 3 h up to 7 days after expo-
sure, each of the eight experimental groups consisted of
six mice, and for the BAL cell isolation experiments, each
of the four experimental groups consisted of five mice.
For the lung cell isolation experiment, each of the four
experimental groups consisted of three mice, and these
experiments were performed independently for four times.
BAL preparation and cell differentiation
3 h, 6 h, 12 h, 18 h, 1d, 3d and 7d, after CNP instillation,
mice were anesthetized via intraperitoneal injection of a
mixture of xylazine and ketamine and sacrificed by
retrobulbar exsanguination. Immediately afterwards,
BAL was performed by cannulating the trachea and
infusing the lungs eight times with 1.0 ml PBS without
calcium and magnesium, as described previously [12, 71].
BAL fluids of the first two lavages were pooled for protein
and cytokine analysis after BAL cell separation by centri-
fugation (425 g, 20 min at room temperature). The cell
pellets were suspended in 1 ml RPMI 1640 medium (Bio-
Chrome, Berlin, Germany) supplemented with 10 % fetal
calf serum (Seromed, Berlin, Germany), and the number
of living cells was counted by the trypan blue exclusion
method. BAL cell differentials were performed on cytospin
preparations (May-Grünwald- Giemsa staining; 2 × 200
cells counted) and the number of polymorphonuclear
neutrophils (PMNs) was used as a marker of inflammation
[12, 71].
Enzyme-linked immunosorbent assay (ELISA)
BAL cytokine concentrations for TNFα, CXCL1, CXCL2
and CXCL5 were determined by commercial ELISAs
(Mouse DuoSet ELISA, R&D Systems, Minneapolis,
USA) according to the manufacturer’s instructions.
Alveolar macrophages isolation
Alveolar macrophages were recovered from the lungs of
mice by BAL with 8 washes of 1 ml PBS at room
temperature. BAL cells were pelleted for 5 min at 425 g
and washed twice in complete RPMI-1640 medium. 2 ×
105 cells were seeded in 12-well plates and were allowed
to adhere for 2 h. Non-adherent cells were removed by
washing two times with PBS.
Alveolar epithelial and CD45+ cell isolation
Alveolar epithelial type II (ATII) cells and CD45+ lung
leukocytes isolation has been described by Mutze and
colleagues before [54, 72]. Briefly, animals where scari-
fied 12 h after water or CNP instillation, and mouse
lungs were lavaged twice with 500 μl of sterile PBS, then
0.9 % saline solution (B. Braun Melsungen AG, Melsun-
gen, Germany) was flushed through the right heart to re-
move blood cells at best. Subsequently, lungs were inflated
with 1.5 ml Dispase (BD Bioscience, San Jose, CA) and
300 μl of 1 % low melting point agarose (Sigma-Aldrich,
Taufkirchen, Germany) and incubated for 45 min at room
temperature. Lungs were minced and four lungs of each
treatment condition were pooled to generate a single cell
suspension by consecutively filtering the crude cell sus-
pension through 100 μm, 20 μm, and 10 μm nylon meshes
(Sefar, Heiden, Switzerland). Single cell suspension was
centrifuged at 200 g for 10 min and the cell pellets were
suspended in DMEM cell culture medium (Sigma Aldrich,
Taufkirchen, Germany). Incubation of the single cell
suspension on petri dishes coated with antibodies against
CD45 and CD16/32 (both BD Bioscience, Heidelberg,
Germany) for 30 min at 37 °C was performed to harvest
macrophages and lymphocytes. Non-adherent cells were
collected and negative selection for fibroblasts was
performed by adherence for 25 min on cell culture dishes.
Again, non-adherent cells were collected and cell viability
was determined by trypan blue exclusion. Cell purity was
assessed by immunofluorescence staining of cytospin
preparations using antibodies for proSFTPC (Merck
Millipore, Darmstadt, Germany), panCK (Dako, Hamburg,
Germany), CD45 (BD Bioscience, Heidelberg, Germany),
and αSMA (Sigma Aldrich, Taufkirchen, Germany).
Finally, CD45+, alveolar epithelial and BAL cells were
collected for RNA isolation.
RNA isolation and quantitative real-time PCR (qRT-PCR)
analysis
For gene expression profiling, lung tissues and BAL
macrophages were prepared for total RNA isolation using
the RNeasy Mini Kit (Qiagen, Hilden, Germany) accor-
ding to the manufacturer’s instructions. Total RNA con-
centrations were analyzed by Nanodrop system (PEQLAB
Biotechnologie GMBH, Erlangen, Germany), and for RNA
quality confirmation the Agilent 2100 Bioanalyzer chip
system (Agilent Technologies, Böblingen, Germany) with
the Agilent RNA 6000 Kit were used. cDNA synthesis was
performed using the SuperscriptII system (Invitrogen,
Carlsbad, USA). Quantitative PCR was performed using
SYBR green ROX mix (Thermo Fisher Scientific,
Waltham, Massachusetts, USA), analyzed by the ABI
Prism Sequence Determination System (Applied Biosys-
tems, California, USA). Gene specific primers are listed in
Table 1 and actin, beta (Actb) and hypoxanthine guanine
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phosphoribosyl transferase (Hprt) transcripts were used as
the housekeeping genes for the standardization of the
relative mRNA expressions. The detailed procedure has
been described by Yin et al. [73].
Immunofluorescence (IF) staining
For purity control of isolated pmATII cells, IF staining
was performed on cells cultured overnight on chamber
slides (BD Bioscience). Cells were subsequently fixed with
acetone/methanol (1:1), and blocked with 3 % (w/vol)
bovine serum albumin (Sigma Aldrich) for 30 min at
room temperature (RT). Primary antibodies (proSFTPC
(Merck Millipore, Darmstadt, Germany), panCK (Dako,
Hamburg, Germany), T1α (Podoplanin; R&D Systems,
Minneapolis, MN, US), CD45 (BD Bioscience), CD31
(Abcam, Cambridge, UK), αSMA (Sigma Aldrich)) were
diluted in PBS containing 0.1 % (w/vol) BSA and
incubated for 1 h at RT. Fluorescently labeled secondary
antibodies (polyclonal goat anti-mouse FITC, Dako,
Hamburg, Germany; goat anti-rabbit Alexa 555 or goat
anti-rat Alexa 555, both Life Technologies) were diluted
in PBS containing 0.1 % (w/vol) BSA and incubated for
1 h at RT. DAPI staining (Roche, Basel, Switzerland) was
performed to visualize cell nuclei.
Statistical analysis
All values are showed as the mean ± SEM of at least five
animals or four independent samples for isolated cells.
We used the analysis of variance (ANOVA), as calcu-
lated by GraphPad Prism 5, to determine the statistical
significance of differences between the experimental
groups. Individual inter-group comparisons were ana-
lysed using the two-tailed unpaired t test with Welch’s
correction. Differences were considered significant at
*, p < 0.05; **, p < 0.01 and ***, p < 0.001.
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